The effect of GLP‐1 (7‐36)amide on bone resorption found in this study contrasts with the results of a study by Christensen and colleagues, where GLP‐1 did not have any acute effect on bone resorption.27 However, that study was done in individuals with type 1 diabetes under hypoglycemic conditions and using lower doses, which may explain the apparent differences. Here, GLP1R is linked to type 1 diabetes mellitus.